Effect of prophylaxis against myocosis in patients with hematological malignancy disease: Efficacy of dosage of itraconazole

Japanese Journal of Antibiotics

Volumn 56, Issue 1, 2003, Pages 61-65

  Toubai, Tomomi ^a   Tanaka, Junji ^a   Fujisawa, Fumie ^a   Kondo, Yoko ^a   Imamura, Masahiro ^a   Ota, Shuichi ^a   Hashino, Satoshi ^a   Yonetumi, Masakatu ^a   Chiba, Koji ^a   Kondo, Takeshi ^a   Toyoshima, Nobuyasu ^a   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ARTICLE; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CANDIDA; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEMATOLOGIC MALIGNANCY; HUMAN; MYCOSIS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; MALE; MIDDLE AGED; MYCOSES; OPPORTUNISTIC INFECTIONS; TREATMENT OUTCOME;

EID: 0037299520     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. GOODMAN, J. L.; D. J. WINSTON & R. A. GREENFIELD: A controlled trial of fluconazole to Prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 326: 845-851, 1992
2. COLEMAN, R.; J. B. ERIC, L. MICHEL, et al.: Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. Clin. Infect. Dis. 28: 331-340, 1999
3. MARR, K. A.; K, SEIDAL, M. A. SLAVIN, et al.; Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up a randomized, placebo-controlled trial. Blood 96: 2055-2061, 2000
4. DAVEY, K. G.; A. D. HOLMES, E. M. JOHNSON, et al.: Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J. Clin. Micobiol. 36: 926-930, 1998
5. VAN CUTSEM, J.: Oral, topical, and parenteral antifungal treatment with itraconazole in normal and in immunocompromized animals. Mycoses. 32 (Suppl.): 14-34, 1946
6. MORGENSTERN, G. R.; A. G. PRENTICE & H. G. PRENTICE: A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. Bri. J. Haematol. 105: 901-911, 1999
7. NUCCI, M.; I. BIASOLI, T. AKITI, et al.: A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Clin. Infect. Dis. 30: 300-305, 2000